Clin2
NCT07165444Likely a fitRecruiting

Comparing two acid-blocking drugs for H. pylori treatment

Potassium-Competitive Acid BlockerProton Pump InhibitorBismuth Based Quadruple TherapyTreatmentHelicobacter Pylori Infection

Part of Digestive system, Infections clinical trials.

This trial tests if a newer acid-blocking medicine works better than a standard one when given with antibiotics and bismuth for treating H. pylori infection, a bacteria that can cause stomach ulcers. It is for adults who have not had treatment for H. pylori before.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
320 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • 18 years old or older
  • Confirmed H. pylori infection from a stool or breath test
  • No prior treatment for H. pylori
  • No antibiotics, acid reducers (PPI), or bismuth in the last 4 weeks
  • No major organ failure, pregnancy, or known drug allergies
  • No stomach surgery in the past

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07358130Recruiting
Comparing two treatments for H. pylori infection

This trial tests two different ways to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach ulcers. One treatment combines three medicines (bismuth, amoxicillin, and vonoprazan), and the other uses four medicines (bismuth quadruple therapy). The goal is to see which works better.

Kaohsiung City
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07285096Recruiting
New quadruple therapy for H. pylori infection

This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.

Jinan
NCT07746934Not yet recruiting
Comparing two antibiotic treatments for H. pylori infection

This study compares two different antibiotic combinations (metronidazole vs. tinidazole, both with bismuth and other medicines) to see which works better at getting rid of H. pylori, a bacteria that can cause stomach ulcers. If you have H. pylori and haven't been treated before, you may be able to help us find the best option.

Ho Chi Minh City, Ho Chi Minh
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang

Hear when a new Treatment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.